Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Taku Yatabe"'
Autor:
Miyuki Chijiiwa, Yoshinari Fujita, Aiko Okada, Taku Yatabe, Yasunori Okada, Tokuhiro Kimura, Masayuki Takizawa, Hideo Matsumoto, Satsuki Mochizuki, Yoshiaki Toyama
Publikováno v:
Annals of the Rheumatic Diseases
Background: Intra-articular injection of hyaluronan (HA) has been suggested to have a disease-modifying effect in osteoarthritis, but little is known about the possible mechanisms. Objective: To investigate the effects of HA species of different mole
Autor:
Toshiro Otani, Yasuo Niki, Yoshiaki Toyama, Shinichi Maeno, Taisuke Tomatsu, Atsushi Funayama, Taku Yatabe, Hideo Matsumoto
Publikováno v:
Biomaterials. 27:1558-1565
Joint effusion after total joint arthroplasty (TJA) is a manifestation of inflammatory reactions within the prosthetic joint. Among the various causes for joint effusion following TJA, deep infection (DI), wear particle-induced synovitis (PS) and met
Autor:
Shinichi Maeno, Yasuo Niki, Taku Yatabe, Hideo Morioka, Tetsushi Taguchi, Hideo Matsumoto, Atsushi Funayama, Junzo Tanaka, Yoshiaki Toyama
Publikováno v:
Biomaterials. 26:4847-4855
Our research group aims to develop an osteochondral composite using type II collagen gel with hydroxyapatite (HAp) deposited on one side. Soaking gels in Ca2+ and phosphate solution is indispensable to HAp deposition, so relationships between cell be
Autor:
Fumihiro Yoshimine, Yasuo Niki, Yoshiaki Toyama, Toshiro Otani, Taku Yatabe, Yasunori Suda, Makoto Kondo, Hideo Matsumoto
Publikováno v:
Biomaterials. 24:3715-3724
Wear particles from prosthetic implants have been shown to cause inflammatory synovitis and periprosthetic osteolysis. These particle-induced pathologies are manifestations of adverse cellular responses to phagocytosed particles. In this study, phago
Autor:
Aiko Okada, Yasunori Okada, Tokuhiro Kimura, Makoto Noda, Taku Yatabe, Masashi Okubo, Yoshiaki Toyama
Reversion-inducing cysteine-rich protein with Kazal motifs (RECK) is a membrane-anchored matrix metalloproteinase regulator, but its functions in cartilage are not fully understood. The aim of the present study was to examine the expression and funct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c6e61bda6b5c6cc14e6cc915371b3c
https://europepmc.org/articles/PMC2877847/
https://europepmc.org/articles/PMC2877847/
Autor:
Takayuki Shiomi, Atsuko Sehara-Fujisawa, Yoshinari Fujita, Yasunori Okada, Aiko Okada, Satsuki Mochizuki, Yukihide Iwamoto, Taku Yatabe, Tokuhiro Kimura, Hideo Matsumoto
Publikováno v:
Arthritis and rheumatism. 58(3)
Objective ADAMs are a gene family of multifunctional proteins. We undertook this study to determine which ADAM species is up-regulated in osteoarthritic (OA) cartilage and to examine its pathobiologic function. Methods Expression of the 13 different
Autor:
Takayuki Shiomi, Satoko Naito, Yasunori Okada, Hiroyuki Enomoto, Koichiro Komiya, Yoshinari Fujita, Aiko Okada, Tokuhiro Kimura, Kyosuke Fujikawa, Miyuki Chijiiwa, Taku Yatabe
Publikováno v:
Pathology international. 57(11)
A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)1, 4, 5, 8, 9 and 15, members of the ADAMTS gene family, have the ability to degrade a major cartilage proteoglycan, aggrecan, at the specific sites, and thus are called 'aggrecan
Autor:
Atsushi Funayama, Yasuo Niki, Junzo Tanaka, Yoshiaki Toyama, Taku Yatabe, Hideo Morioka, Tetsushi Taguchi, Shigeru Yanagimoto, Shinichi Maeno, Hideo Matsumoto
Publikováno v:
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association. 13(3)
Recently, tissue-engineered chondrocyte transplantation has been tried to treat full-thickness cartilage defects. We developed an injectable type II collagen gel scaffold by chemically reacting type II collagen with polyethylene glycol crosslinker. T
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 63
Autor:
Toshiro Otani, Yoshiaki Toyama, Yasuo Niki, Fumihiro Yoshimine, Makoto Kondo, Taku Yatabe, Hideo Matsumoto
Publikováno v:
Biomaterials. 26(9)
Metal sensitivity (MS) reactions to implant metals represent a rare but well-documented complication following total joint arthroplasty (TJA). Although 20-25% of post-TJA patients develop MS, only a few highly susceptible patients (< 1%) exhibit symp